Category: Vaccine Headlines
60% of Americans say they probably won’t get an updated COVID-19 vaccine
Pew Research Center Six-in-ten Americans say they will probably not get an updated 2024-25 COVID-19 vaccine, according to an October Pew Research Center survey. Smaller shares say they probably will get an updated vaccine (24%) or have already received one (15%). The Centers for Disease Control and Prevention has recommended the updated vaccine to everyone ages 6 months and […]
Nov 20, 2024
The stunning success of vaccines in America, in one chart
Vox America, before and after vaccines. Measles, mumps, and polio are supposed to be diseases of the past. In the early to mid-20th century, scientists developed vaccines that effectively eliminated the risk of anyone getting sick or dying from illnesses that had killed millions over millennia of human history. Vaccines, alongside sanitized water and antibiotics, have marked the […]
Nov 19, 2024
Why getting your flu and COVID-19 vaccines before the holidays is a good idea
PBS Newshour If you missed the early fall push for flu and COVID-19 vaccines, it’s not too late. Health officials say it’s important to get vaccinated ahead of the holidays, when respiratory bugs tend to spread with travel and indoor celebrations. Those viruses haven’t caused much trouble so far this fall. But COVID-19 tends to […]
Nov 13, 2024
Another Avian Influenza mRNA Vaccine Candidate Advances
Precision Vaccinations Arcturus Therapeutics Holdings Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a “Study Can Proceed” notification for the Company’s Investigational New Drug application, ARCT-2304, a self-amplifying mRNA (sa-mRNA) vaccine candidate for active immunization to prevent pandemic influenza disease caused by H5N1 virus. The sa-mRNA vaccine candidate is designed to make many […]
Nov 12, 2024
Battling Infectious Diseases in the 20th Century: The Impact of Vaccines
WSJ The number of infected people, measured over 70-some years and across all 50 states and the District of Columbia, generally declined after vaccines were introduced. The heat maps below show number of cases per 100,000 people.
Nov 12, 2024
Do the Covid vaccines provide long-lasting protection?
NBC News The CDC is recommending that older adults get a second Covid shot in the spring. How durable are the vaccines? In October, the Centers for Disease Control and Prevention recommended that high-risk adults get a second updated Covid vaccine to bolster their protection against the virus. The agency now recommends that people ages 65 and up and […]
Nov 6, 2024
Why protective antibodies fade after COVID-19 vaccines
NIH Some vaccines offer long-lasting protection. For instance, the tetanus vaccine provides protection for at least 10 years. With other vaccines, protection may begin to decline within a few months. To provide enduring immunity, a vaccine must elicit production of long-lived plasma cells, a type of immune cell that matures over time in the bone […]
Oct 30, 2024
Comparing the COVID-19 Vaccines: How Are They Different?
Yale Medicine COVID-19 is now in its fifth year, and the subvariants of the Omicron strain continue to drive infections in the United States. The good news is that vaccines, which have been updated each year since 2022, are still expected to be effective at preventing severe disease, hospitalization, and death from COVID. In the U.S., infants, children, […]
Oct 29, 2024
Why You Might Need Two COVID-19 Shots This Season
Time eniors and people who are immunocompromised should get not just one but two COVID-19 shots this respiratory virus season. That’s the new recommendation from the U.S. Centers for Disease Control and Prevention (CDC). People in these groups should get the vaccines six months apart in order to stay protected against the disease, the agency’s vaccine group […]
Oct 29, 2024
Pfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59
Contagion C3671023 Substudy A (NCT05842967)(MONeT Study) is a phase 3, randomized, double-blind, placebo-controlled trial assessing the safety and immunogenicity of Pfizer’s RSVpreF vaccine in high-risk adults aged 18-59 with chronic medical conditions, such as pulmonary, cardiovascular, hepatic, renal, and metabolic disorders, including diabetes mellitus. The study aims to show that the immune response in this […]
Oct 23, 2024